Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • Feb. 13, 2026, 08:32 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Universe Pharmaceuticals Inc - Ordinary Shares. New value: Universe Pharmaceuticals Inc - Class A Ordinary Shares.

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Technical Exchange News
  • Feb. 13, 2026, 08:27 UTC
  • 33
  • 0 comments

Avadel Pharmaceuticals (AVDL) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Technical Exchange News
  • Feb. 13, 2026, 00:10 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Avadel Pharmaceuticals plc - Ordinary Share.

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Technical Exchange News
  • Feb. 13, 2026, 00:10 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Avadel Pharmaceuticals plc - Ordinary Share. New value: Avadel Pharmaceuticals plc - Ordinary Share.

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Technical Exchange News
  • Feb. 13, 2026, 00:10 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Avadel Pharmaceuticals plc - Ordinary Share.

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • Feb. 13, 2026, 00:10 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Universe Pharmaceuticals Inc - Ordinary Shares. New value: Universe Pharmaceuticals Inc - Class A Ordinary Shares.

Comment Full text

60 Degrees Pharmaceuticals Inc (SXTP)

  • Technical Exchange News
  • Feb. 12, 2026, 02:47 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mangoceuticals Inc (MGRX)

  • Technical Exchange News
  • Feb. 12, 2026, 02:47 UTC
  • 25
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Lexaria Bioscience Corp. (LEXX)

  • Technical Exchange News
  • Feb. 12, 2026, 02:47 UTC
  • 31
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • Technical Exchange News
  • Feb. 12, 2026, 02:47 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 139
  • 140
  • 141
  • 142
  • 143
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(271556)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157975)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin